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STUDY PROGRAM FOR BIOCHEMICAL
MONITORING BY PARDTID SECRETION
I. 0 INTRODUCTION
This report by Beckman Instruments, Inc. is the result of a program on
biochem£cai monitoring of biochemical changes in body flulds u_de_ _ varyfng
I
I
conditions by parotid secretion.
In pursuit of this program more than two thousand analyses were made on
body fluid samples from 102 different subjects. The subjects were of three
I a_=e_nct___.... =_ __¢_ ,=_n,,,=viz. !) normal, oT...........gen_rnl population:. 27. hospitalized
patients; 3) a select group of marine pilots. The homogenous third group
was subjected to a series of body function tests. Sampling of this group
I
for the various chemical components was also done during exercise and post-
exercise periods. As a result, the present program offered a total of
I five test populations.
I
I
I
A significant addition was made to the original scope of this program
through the efforts of the men in this specialized group. It was comprised
of nine officers from the E1 ToroMarine Corps Air Station, California.
They contributed a great amount of time, effort and body fluids and made
possible the collection of some of the valuable data presented here. An
I expression of appreciation is extended to them for their participation in
the program.
i-i
II
I
I
I
I
I
I
I
I
I
I
I
I
2.0 OBJECTIVE
In Phase I, the contractor undertook extensive laboratory experimental work
and analysis to prove the feasibility of one or more physiochemical and
biochemical methods for comparing the parameters listed in Table I. Work
included extensive investigation and design of sampling and collection
techniques.
TABLE I
Clinical Determinations
No. Parotid No. Blood No. Urine
Test Samples Samples Samples
I. p02 60 30 --
2. pCO 2 60 30 --
3. HCO 3 60 30 --
4. Urea 60 30 --
5. NH 3 60 30 __
6. Ca 60 30 60
7. Total Protein 60 30 30
8. Glucose 60 30 30
9. Cholinesterase 15 15 --
i0. VMA 15 15
IiI
I
I
I
I
I
I
I
I
I
3.o s_Y
The feasibility of monitoring biochemical changes in parotid secretion
under varying conditions has been demonstrated.
Simple body function tests rapidly elicited distinct changes in concentra-
tion of p_rotid components greatly in excess of those evidenced in other
monitored body fluids. The potential use of parotid secretion as an indi-
cator of physiological changes is clearly documented. A statistical com-
parison of mean concentrations of several components in parotid showed
the marine control group to be separate from the normal and hospitalized
populations. The ability to differentiate between groups with varying
backgrounds is strong evidence that the parotid secretion is sensitive to
physiological changes.
In general, material concentrations in parotid fluid are lower than in blood.
However, reliable assays were routinely achieved for all the considered
parameters except for cholinesterase and vanillylmandelic acid. It is
believed that automatic measurements for partial pressures of oxygen and
carbon dioxide and bicarbonate concentration can be evolved from present
state-of-the-art techniques. Calcium, protein, and glucose require more
effort, while urea and ammonia appear even more difficult with present day
instrumentation.
Specific conclusions from the data obtained are:
o It is feasible to monitor biochemical changes in parotid secretion
I under varying conditions
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o Automatic measurements of several parameters are feasible
o Non-stimulated flow rates are adequate for monitoringany one oF
two specific components. However, for sequential analysis of several
components_ stimulated flow rates are recommended.
o Parotid fluid appears to be a mechanism to detect physiological
changes; further work is necessary, however, to completely define
these relationships:
o Parotid fluid partial pressure of oxygen is a more pronounced indi-
cator of metabolic changes than venous blood partial pressure of
oxygen.
o The effect of exercise on the level of calcium in parotid fluid is
to elevate the concentration.
o Ammonia concentration in parotid fluid reflects the effects of
body function tests.
o Cholinesterase and vanillylmandelic acid concentrations are below the
levels of sensitivity of the methods currently available for their
detection.
o Parotid urea-nitrogen concentrations reflect the blood urea-nitrogen
concentration and may be utilized to evaluate those metabolic con-
ditions associated with variations in concentration of blood urea
nitrogen.
o Protein concentration can distinguish different populations; however,
further study on protein concentrations in parotid fluid is necessary
to establish the meaning of such variations in concentration.
o The partial pressure of carbon dioxide in parotid fluid and the
bicarbonate concentration of parotld fluid can distinguish between
certain populations.
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o Glucose concentration in parotid fluid can be utilized for
studying the relationships of glucose metabolism under varying
conditions.
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4.0 RESULTS
The total number of analyses made for the various fluid components is
shown in the sample status sheet on Page 4-2. Despite the fact that the
sampling requirements have been greatly exceeded for most components, the
data is minimal when divided into the various populations. It should be
noted that the major portico, of the data is based on stimulated parotid
flow. This was necessary to obtain adequate volume since duplicate samples
were analyzed in eight different procedures.
Stimulation caused a decrease in the concentration of the parotid compo-
nents (except for post-exercise glucose), but did not otherwise change
the relative levels of the components. Blood values were not significantly
influenced. Non-stimulated flow data is included for comparison. The data
presented is based on only a few cases.
The reduced data, permitting a comparison between the parotid, blood, and
urine values, is presented in Appendices A, B, C, D, and E. Specific
results comparing the test populations are shown below. These are for
stimulated flow unless noted.
I) The mean values for stimulated parotid flow were similar for all
test groups under quiescent conditions, viz., 1.14 to 1.2 ml/min
when bilaterally collected.
2) With exercise, the control group stimulated parotid flow rate
decreased to 0.84 ml/min, a drop of about 26%.
3) Non-stimulated flow rates under quiescent conditions averaged
0.04 ml/min.
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4) Average partial pressure of oxygen of parotid fluid was 95 mm Hg
for the normal group, 87 for the hospitalized, and 81 for the
control group.
5) The partial pressure of oxygen In parotid fluid decreased 31%
after exercise. The blood value increased 9%.
6) Parotid carbon dioxide partial pressures varied from 32 mmHg
for the normal group to 34 for the hospitalized patients, and
38 for the control group.
7) The partial pressure of carbon dioxide was about 7% lower after
exercise while the blood value dropped 10%.
8) Parotld bicarbonate values were 14.4 m moles/l for the normal
group, 13.8 for the hospitalized, and became elevated to 21.6
for the control group.
9) After exercise, parotid bicarbonate had dropped 10%while the
blood value decreased 16%.
i0) Urea concentrations in parotid fluid were 9.2 mg% in the normal
group, 12.1 in the hospitalized, and 8.8 in the control group.
Ii) Parotid urea increased 17.5% after exercise but blood decreased
about 3.5%.
12) Parotid ammonia measured 127 ug% in the normal group, 142 in the
hospltalized, and 114 in the control group.
13) Parotid ammonia increased rapldly during exercise, rising 48%.
After exercise it dropped to an elevation of only 5%. Blood ammonia
remained substantially constant with a post exercise drop of only
1%. Blood, of course, was not measured during an exercise period.
4-3
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14) Mean calcium levels in F_rotid fluid for the various populations
were 1.73 meq/l for the hospitalized, 1.70 meq/l for the normal,
and 1.65 meq/l for the control group.
15) Parotid calcium level increased 11.5% post exercise while blood
increased 1.5%.
16) Protein concentrations in parotid fluid were 201 mg% for the normal
group, 234 mg% for the hospitalized, and 131 mg% for the control
marine population.
17) Post-exercise parotid protein increased 43% while blood went up 6%.
18) Glucose concentrations in parotid fluid are 0.95 mg% for the control
group, 0.98 mg% for the hospitalized group, and 1.37 mg% for the
control marine group.
19) Glucose, post-exercise, was up 177% while in blood it dropped
about 7%. Non-stimulated flow also showed an increase, but only
35%, based on just 3 cases. Blood again decreased, 8% in this
sampling.
It is evident that parotid secretion shows marked variation in different
select groups and under varying metabolic conditions.
4-4
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5,0 DISCUSSION OF DATA
Over 2000 analyses were made on paroti_bloo_and urine samples on 102
different subjects from various groups of individuals. These groups are
described, along with the sampling technique utilized, in Appendix F.
The samples were analyzed by the procedures defined in Appendix G. The
resulting data has been tabulated in AppendixA. An analysis of the
data appears in Appendix C, D and E.
The five groups studies are defined as:
i) Normal: Individuals who are amb_|_and not undergoing any
known medical treatment.
2) Hospitalized: individuals u_dergoir_ medical treatment within
the confines of a hospital
3) The pilots from the E1Toro Marine Base prior toControl:
exercise
Exercise:4) The marines during the body function test period
(30 minute biodynamic period)
5) Post-Exercise: The marines after the completion of the
test period.
A discussion of the various components investigated is described in
subsequent sections.
5.1 The Partial Pressure of OxTKen in Parotid Fluid
The partial pressure of oxygen in parotid fluid was determined by Beckman
Model 160 Physiological Gas Analyzer. The instrument utilizes a polaro-
graphic technique for measuring pO2. The stability, reproducibility and
5-1
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sensitivity of the technique is described in Appendix G. Calibration
of the instrument was achieved by using atmospheric oxygen partial pressure
for the upper limit and a prepared bottled gas mixture of CO 2 - N2 for
zero oxygen partial pressure.
The pO 2 in parotid fluid ranged from a low of 30 mmHg in the post-exercise
marines to a high of 142 mmHg in the no_--al population. The means for the
five populations sampled ranged from a low of 55.6 mm Hg (of the post
exercise marines) to a high of 95_n Hg (for the normal group) as shown
in Appendix A. By applying the t-test, an estimation of the probability
that the means of these various samples are from different populations was
tabulated in Appendix B. Those showing a highly significant probability
of being different populations are:
i) Normal and exercise means
2) Normal and post-exercise means
3) Hospitalized and exercise means
4) Hospitalized and post-exercise means
5) Control and post-exercise means
A significant probability of being different populations is exhibited by:
1) Normal and control means
2) Control and exercise means
3) Exercise and post-exercise means
It would appear from the analysis that it may be possible to distinguish
various populations by the partial pressure of oxygen in parotid fluid.
Examination of the marine population which has been subjected to physical
activity shows a significant decrease in the oxygen partial pressure in
5-2
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the parotid fluid, viz., from a mean of 81.2 n_ Hg to 66.6 mm Hg
(Appendix A). This decrease in oxygen partial pressure continues and
is still evident in the post-exercise mean. In fact, the post exercise
mean is statistically significantly lower than the exercise mean (Appendix _).
It is possible to distinguish the three different populations (control, exer-
cise, and post-exercise) by the oxygen partial pressure in parotid fluid
(Appendix B). W_en c_--mparing the venous partial pressure values for the
pre- and post-exercise populations, it is not possible to distinguish between
these groups. Thus, or_may speculate that parotid fluid is a more sensitive
indicator than venous blood for evaluating the metabolic changes via the
partial pressure of oxygen.
5.2 The Partial Pressure of Carbon Dioxide in Parotid Fluid
The partial pressure of carbon dioxide in parotid fluid has a lower mean
value than the value of blood when measured by the Beckman Physiological
Gas Analyzer with a Severinghaus-type electrode (Appendix A). The range
measured was 17 nzn Hg (from the post-exercise group) to 51 n_n Hg (from the
pre-exercise group). The means of the five groups ranged from a high of
37.8 n_ Hg (marines) and a low of 31.8 mm Hg (the normal group). The t-test
revealed that there was a 99% chance that the control group and the normal
group are two different populations and that there was a 95% chance that
the hospitalized and control groups are two different populations (Appendix
B). When this control group is subjected to exercise, the mean values
drop and approach the values obtained for the normal and hospitalized groups.
From a statistical standpoint we can no longer distinguish between the groups.
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Although it is not possible at this time to determine the significance of
different populations for pCO2 concentrations, it does appear that they do
exist.
5.3 Bicarbonate Concentration in Parotid Fluid
Values for the bicarbonate concentration in parotid fluid were obtained
employing the Beckman Physiological Gas Analyzer for measuring pH and
pCO 2 of the fluid, and using these values =- _^ u^__ ..... -,==olg=lrh
equation (Appendix G). The range measured in parotid fluid was from a low
of 5.7 millimoles per liter (normal group) to a high of 34 millimoles per
liter (exercise group). The mean values of the five populations ranged
from a low of 13.8millimoles per liter (hospitalized group) to a high
of 21.6 millimoles per liter (marine group). In the analysis of the normal
and hospitalized groups it is not possible to distinguish any differences
in population. They appear to come from the same population. However the
marine control group appears to be a different population. The t-test shows
a 0.999 probability of a different population (Appendix B). Exercise de-
creased the mean concentration by approximately 12%. There is a 0.9
probability that this exercised population is a different group from the
control marines prior to the exercise cycle.
Why the mean concentration of bicarbonate in parotid fluid is so much higher
in the marine population cannot be explained. However, this difference
does appear to exist. The instrumentation was calibrated in an identical
manner for each series of samples. The same calibration standards were
used, i.e., buffer and prepared bottle gas. It is therefore highly unlikely
5-4
that the values obtained were due to an error in calibration standards or
technique. It would appear then that bicarbonate concentration can be used
to distinguish between certain populations.
5.4 Calcium Concentratlon in Parotid Fluid
Calcium levels in parotid fluid for the five test populations tend to have
very similar mean values and standard deviations except for the post-exerclse
group which shows approximately 12% higher mean value (Appendix A).
This group can be recognized statistically from the other groups (Appendix B).
The range found in parotid fluid for calcium is 1.0 meq/l to 3.6 meq/l. The
control marine group bad the lowest mean value of 1.65 mg% as compared to
the highest mean value of 1.84 meq/l, which was the postffiexercise marine
group.
It would appear that the effect of exercise on the level of calcium in
parotid fluid is to elevate the concentration. No such elevation can be
seen in the blood mean values of these groups. Parotid fluid would thus
appear to be a meaningful but yet uninterpreted indicator of change.
5.5 Ammonia Concentration in Parotid Fluid
The ammonia concentration in parotid fluid shows a significant increase
when the control marine group is subjected to exercise. There is a mean
!
value increase from 114 mg% to 179 mg%, a rise of 48%. After the completion
of the exercise cycle the level dropped to the baseline values again
(Appendix A). No significant difference in sample means can be found for
the other groups. The range for ammonia concentration in parotid fluid is
from a low of 45 mg% (marine control) to a high of 354 mg% (exercised
marines). The mean levels of ammonia found in blood were approximately
5-5
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10% higher for the groups measured. No information is available, however,
for the exercising marine group for blood.
In general it would appear that ammonia concentration in parotid fluid
reflects the effects of body function tests. Thechange in level is dramatic
and appears to be consistent within the individual (Appendix D).
The probability of the control and exercise means which are measured
from different populations is 0.9? (Appendix B). This leads to the assump-
tion that parotid fluid can be utilized to reflect metabolic activity
of this component.
5.6 Cholinesterase (Pseudocholinesterase)
No significant amount of pseudocholinesterase was found in over 60 parotid
fluid samples analyzed. Several methods and modifications of existing tech-
niques were utilized in an attempt to obtain values for parotid pseudo-
cholinesterase. No suitable method was found. The effective level of
pseudocholinesterase is below the sensitivity of the methods currently in
use. It may be possible, however, to develop a technique to measure cholin-
esterase in parotid fluid. This would be a burdensome program and appears
that pseudocholinesterase is not feasible for such measurement at the
present time.
5.7 VanillTlmandelic Acid (VMA)
The levels of VMA in parotid fluid are below the levels of sensitivity of
the current method utilized for the measurement of VMA. No VMAwas found
in any of the 15 samples tested. It would appear that VMA is not a feasible
material to monitor in parotid fluid at this time.
5-6
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5.8 Urea NitroEen Levels in Parotid Fluid
Parotid urea-nitrogen concentrations reflect the blood urea-nitrogen values.
The linear equation Y = 14.7 + 0.8 (X-9.87)
where X w concentration of urea nitrogen in parotid fluid
CragS)
Y = concentration of urea nitrogen in blood (mg%)
expresses the relationship.
Linear regression analysis of the component reveals a correlation coefficient
of 0.8 for the values of the various groups tested. The range of urea nitro-
gen in parotid fluid varies from a low of 3.0 mg% (normal) to a high of
53 mg% (hospital). See Appendix A. In evaluating the various groups for
differentiation be_een groups the foil_owing populations can be distinguished:
i) Normal and post-exercise groups
2) Normal and hospitalized groups
3) Control and exercised groups
4) Control and post-exercise groups
Based on the fact that parotid values for urea nitrogen can predict blood
values it should be possible to use parotid fluid to evaluate those meta-
bolic conditions which are indicated by an elevated or decreased level of
blood urea-nitrogen.
5.9 Protein Concentration in Parotid Fluid
Protein concentration in parotid fluid varies widely among individuals.
A range from 35 mg% (marine group) to a high of 999 mg% (an alcoholic from
the hospitalized group) was found. The range for mean values for the five
groups studied is from a low of 131 mg% for the control group to a high of
234 mg% for the hospitalized group (Appendix A).
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By applying the t-test, an estimation of the probability that the means
of the various samples are from different populations was tabulated
(Appendix B).
The populations that can be distinguished are:
I) Normal and control groups
2) Hospitalized and control groups
3) Hospitalized and exe_clse groups
The marine groups show an increase of 43% in the mean value post-exercise.
However, when subjecting these two groups (control and post-exercise) to the
t-test, there is only a probability of 0.9 that they are from different
populations (Appendix B). A 0.95 or 0.99 probability would be more desirable
in order to draw conclusions as to the feasibility of parotid fluid for
biochemical monitoring. However, a probability of 0.9 at least may be
interpreted as showing a tendency. Further studies on protein concentrations
in parotid fluid would probably reveal whether or not exercise causes this
rise.
5.10 Glucose Concentration in Parotid Fluld
Glucose concentration in parotid fluid is two orders of magnitude lower
than that found in blood. The mean value of glucose in parotid fluid is
approximately 1 rag%; however, values as high as 5.60 rag% and as low as
0. I rag% were noted.
No distinction between the normal, hospitalized and control populations
could be made statistically (Appendix B). A study of the marlne population
without stimulation (Appendix A) reveals an increase in glucose concentration
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post-exercise of 39%. In the post exercise group using the lemon stimulant
(an average of 7 stimulations over the test period) a highly significant
increase of 177% was found.
Since the method of stimulation (Appendix F) was normally of this type
it was necessary to establish that there was no leakage into the collection
cup. Since the system requires a positive head pressure to m_je the fluid
down the capillary tubing, if any leakage occurred it would be in an outward
direction rather than inward. However, in order to substantiate this fact,
citric acid was used as a stimulant. If any leakage inward was occurring,
a change in pH of the parotid fluid should be noted. No change could be
detected. A glucose tolerance test was performed. With the collector in
place the subject was given a concentrated solution of glucose to injest
(i00 g diluted with 400 ml of H20) , a concentration far above that normally
used. No elevation in glucose was noted in the parotid fluid during or
immediately after the ingestion period. One-half hour after the ingestion,
the glucose level increased approximately 70% and continued to rise to a
value of 8.2 mg%, an increase in level of 120% over the base line value
of 3.4 mg%. The level of glucose returned to the baseline value by the
second hour and dropped below baseline by three hours. These observations
lead to the conclusion that values reported for glucose are due to metabolic
activity rather than from external contamination.
An average of i to 2 lemon stimulants were used for stimulation purposes
for the normal, hospitalized and control data. The sampling time was
usually less than 20 minutes. By rigid control of the collection technique,
a comparison of the various populations can be made (Appendix B).
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It would appear that glucose values in parotid fluid can be utilized for
studying the relationships of glucose metabolism under varying conditions.
Sensitivity of the me_odology for the measurement of glucose in parotid
fluid has been developed to 1 part per million, although the method does
require careful technique.
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6.0 REC_TIONS;
In order to maximize the utility of parotld secretion and to predict the
continuing capability of personnel operating space craft or high perform-
ance vehicles_ additional information should be accumulated.
The following list of recoulnendations delineates the areas which at this
1) Deviations of individual values from group means (Appendices Aj
D and E) are such that biological and physiological characterization can
only be achieved by monitoring individual subjects for extended periods.
Diurnal variations must be elucidated. A specific program calling for
multi-sampllngs daily over a period of several months appears necessary
to interpret parotid secretion in terms of physiological change on a se-
lect subject.
2) Variations in physical characteristics of parotid fluid such as
conductivity and density might profitably be explored for biochemical
relationships.
3) Examination of biochemical changes in other parotid components
than those currently considered may be helpful in predicting physiologi-
cal changes. Materials suggested for study include amylase 2 ketoster-
oids_ selected protein fraction% and total carbohydrates.
4) Specific metabolic processes should be studied to correlate
pathological and physiological changes with changing parotic fluid values_
e.g. a study of elevated ammonia in hepatic insufficiency might be corre-
lated with parotidaum_nia levels.
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APPENDIX A
DATA TABLES
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COMPARISON OF MEAN VALUES WITH/WITHOUT
STIMIILATION - MARINES ONLY
Parot_d
Uru m8%
Ca m_q/1
Prot. rag%
Glu. mE%
i Blood
Urea rag%
h'H3 ug%
I Prot. gZ
Glu. mE%
Urin_____e
Ca meq/1
Glu. mE%
Pre-Exercise
With
i
1.6
131
1.4
14.0
127
7.1
97
I
2.0
Withmat
i
!
15
2.2
189
1.4
14. I
114
7.0
122
6.0
2.7
Exercile
With
i0. i
1.6
139
1.9
Without
19.7
2.6
217
2.1
Post-Exerclse
With
10.3
1.8
188
3.8
13.5
125
7.6
91
w
1.7
Without
16.0
2.7
326
1.9
13.8
115
7.4
112
9.1
4.1
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APPENDIX B
STATISTICAL TABLES
PARTIAL PRESSURE OF CARBON DIOXIDE
IN PAROTID FLUID
POPULATIONS STUDIED
I
I
I
i
I
I
!
NORMAL
NORMAL
(2)
HOSPITAL
(3)
CONTROL
(4)
EXERCISE
(s)
POST-
EXERCISE
HOSPITAL
CONTROL
EXERCISE
POST-
EXERCISE
0,99 0.95
0.975 0.8
0.99 0.975 0.8
0.95
I
I
I
The probability is presented that the mean values for the parotid parameter
are from different populations. A probability of 0.99 or greater is con-
sidered highly significant; 0.95 significant; and 0.90 showing only a trend.
Any probability below 0.90 is inconclusive.
B-I
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I PARTIAL PRESSURE OF OXYGEN IN PAROTID FLUID
POPULATIONS STUDIED
• I
NORMAL
(1)
NORMAL
i 'I
(2)
HOSPITAL
(3)
CONTROL
I (4)
EXERCISE
POST-
EXERCISE
O.95 0.995 0.999
,o,,,,A.0.8 0.8 0.995 0.999
_o_.,o.0.95 O.8 0_75 0.999
_,.,,_,s,=0.995 0.9950.975 0.95
POST-
EXERCISE
0.999 0.999 0.999 0..95
The probability is presented that the mean values for the parotid parameter
are from different populations. A probability of 0.99 or greater is con-
sidered highly significant; 0.95 significant; and 0.90 showing only a trend.
Any probability below 0.90 is inconcluslve.
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BICARBONATE IN PAROTID FLUID
POPULATIONS STUDIED
(1)
NORMAL
NORMAL
HOSPITAL
CONTROL
(2)
HOSPITAL
(3)
CONTROL
(4)
EXERCISE
| ,a
(5)
POST -
EXERCISE
Q999 0.975 0.97 5
0.999 0.995
Q995 Q995 Q995
EXERCISE 0.975 Q995 0.9 0.6
POST -
EXERCISE 0.975 0.995 0.9 0.6
The probability is presented that the mean values for the parotid parameter
are from different populations. A probability of 0.99 or greater is con-
sidered highly significant; 0.95 significant; and 0.90 showing only a trend.
Any probability below 0.90 is inconclusive.
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AMMONIA IN PAROTID FLUID
POPULATIONS STUDIED
NORMAL
CONTROL
(!)
NORMAL
.7
(2)
HOSPITAL
(3)
CONTROL
_E'_"' 0.9 0.8 0,975
POST-
EXERCISE
(4)
EXERCISE
!
B IPIL
POST-
EXERCISE
0.975 0.6
0.95
0.95
The probability is presented that the mean values for the parotid parameter
are from different populations. A probability of 0.99 or greater is con-
sidered hlghly significant; 0.95 slgn/ficant; and 0.90 showing only a trend.
Any probability below 0.90 is inconclusive.
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NO_L_L
HOSPITAL
III
CONTROL
EXERCISE
POST-
EXERCISE
UREA-NITROGEN IN PAROTID FLUID
(I)
NORMAL
0.975
O.8O0
O.gOo
0.950
POPULATIONS STUDIED
(2)
HOSPITAL
0.9"/5
|
O.9OO
i L I
0.800
0.8O0
(3)
CONTROL
0.800
0.900
o. gso
0.950
JJ i n
(4)
EXERCISE
0.900
0.800
0.950
O.GOO
Iw,%
POST-
EXERCISE
0.950
0.800
0.950
0.600
I
I
The probability is presented that the mean values for the parotid parameter
are from different populations. A probability of 0.99 or greater is con-
sidered highly significant; 0.95 is significant; and 0.90 showing only a
trend. Any probability beZow 0.90 is inconclusive.
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I PROTEIN IN PAROTID FLUID
I POPULATIONS STUDIED
I _'NORMAL (1) (2) i (3) ! (4) P_T- I
I 0.8 10.95 0.9 0.6
,
il ...........
i
I
I
I
I
I
!
_o,,,,,o,0.95 0.95 0o6 0.9
EXERCISE
POST -
EXERCISE
0.95
The probability is presented that the mean values for the parotid parameter
are from different populations. A probability of 0.99 or greater is con-
sidered hiEhly significant; 0.95p slgD/flcant; and 0.90 showlng only a
trend. Any probability below 0.90 is inconcluslve.
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CALCIUM IN PAROTID FLUID
POPULATIONS STUDIED
I
NORMAL
HOSPITAL
CONTROL
(i)
NORMAL
(2)
HOSPITAL
!
(3)
CONTROL
(4)
EXERCISE
I (2)
POST-
EXERCISE
EXERCISE 0.7 0.8 0.5 0.975
POST-
EXERCISE 0.9 0.9750.975
The probability is presented that the mean values for the parotid parameter
are from different populations. A probability of 0.99 or greater is con-
sidered highly significant; 0.95 is significant; and 0.90 showing only a
trend. Any probability below 0.90 is inconclusive.
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IGLUCOSE IN PAROTID FLUID
POPULATIONS STUDIED
NORMAL
HOSPITAL
CONTROL
(Marines)
(1)
NORMAL
(2) (3)
HOSPITAl. CONTROL
i
0.5 0.9
i|
0.9
0.9
The probability is presented that the mean values for the parotld parameter
are from different populations. A probability of 0.99 or greater is con-
sidered highly significant; 0.95s significant; and 0.90 showing only a trend.
Any probability below 0.90 is inconclusive.
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APPENDIX C
HISTOGRAMS OF PAROTID COMPONENTS
FOR ALL TEST POPULATIONS
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APPENDIX D
Graphs showing the variation of monitored parameters
for each individual in the control group with repeated
testing. Parotid values shown.
ZI
POz
I ._
II
IPCO_./
@-----. ..=...
A
| --/" ,\
i uRE_ \,._
I 7 --_
\
/
/
_..-o
PROT.
GLUC.
|IPo_
| "--. -
!
2_
P_CYI'.
/
/,
/"
X
X
OkEA
/
GLUG.
P--' ;!I
\
\
\
I
|PCOz
I
I
i
I I
\
\
\
I
I
3
g.
:r
J
L
0
i i J i
\
\
4
i -
J
i
iPRO'[.i
t
J
J
.
l"
J
IJ
.
i.#'
J
!|
I
ill
|FO.,?_
!
\
\
b
4
D.
!
|9C0
II,
P_OT.
k
--"---,-- _
|_IP.Et I------
_', o.._._._i -'_
!
_LUC.
/%
/ \
/ \
/ \
J
?
/
/
/'
/
/
A
w
,I
I
IPo_
I
5
CI. ,a
J
I
|PCOz.
i
i
i ..........
--,...
--.,.
-iuco__--\ _ --__.
! -----.
PRO1-.
0
I
I /_/ _.i_
!
_LL_C. /
i
i
i, co_. \ ,i ...........
,l
\ / ....
II % _
Ill \ "> \
t..O_, \ '/ '
! 9_9£' • /t , ,,,,,i
\
It
f
I
I
1
1
I
t
I
\ o
\
\
/z
./
t.-
C
"7
/ °
, 3
!
/
l
/
L
w It
1
I
I
I
\
\
f
L
/
JI
LUCo
/
I
I
I
Ipco_
I
8
/
C_
_---- .___._
/
/
PR}-r. </
/!
/
!
/
%LUC
I
I
F
P02.
I
I
J
J
I
9
i
L..__
JPc_k
I '"-
I
ilnco, ":,,.
...-.%
,
@LUC.
o. ._ r
of
/
o
I
/-0
J
J
APPENDIX E
Graphs showing the variation of monitored parameters
for each individual in the control group with repeated
testing. Blood values shown.
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APPENDIX F
BODY FLUID COLLECTION TECHNIQUE
APPENDIX F
Body Fluid Collection Technique
AREA I - PHYSICAL FACILITIES
Arrangements were made with two large hospitals in the Los Angeles area
for appropriate space in which our technicians could obtain body fluid
specimens. The first of these was Harbor General Hospital (a branch of
the Los Angeles County Hospital System), which has a 600 bed rating and
is located in Torrance, California. The sampling area was in the Recovery
Room of the Urology Clinic Unit. The room is fifteen by thirty feet and
contains ample working area, refrigeration equipment, comfortable seating
and a quiet, restful environment.
The second facility was established at Orange County Hospital which has
a 700 bed rating and is located in Orange, California. The Head and Neck
Treatment Room containing ample working area, dental chair seating, excel-
lent lighting and a quiet, restful atmosphere was made available for our
collections.
At various times during the project it was necessary to use our own labor-
atory facilities at Fullerton to sample in-house personnel associated wlth
the study and select volunteers. Also, at times it was difficult for sub-
Jects to report to a central sampling location within the hospital, thus
necessitating setting up of a remote sampling depot to handle personnel
from a particular unit.
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The control group study was initiated and maintained at the E1 Tot. Base
Hospital where we received full use of the Solarium area for our sampling.
I
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I
I
At all times, whether sampling at a central hospital location, a designated
unit within the hospitals, or our own laboratory, the following conditions
were met:
I.
2.
3.
Subject comfort
Freedom from distraction and disturbances
Non-stressful environment
AREA II - DISCUSSION OF POPULATION GROUPS
I.
"Control" Group Descriptlon - Nine officers at the U. S. Marine Corps
Air Station, E1 Toro, volunteered to participate in the parotld fluid
study program. Except for one subject, all men have pilot assignments
ranging from reconnaissance to high performance aircraft. Their ages
were from 26 to 35. None of the subjects were under medical treat-
ment except subject #2 who was taking appetite depressant tablets.
Subject #2 also was treated for mononucleosis in April 1961. This
was the only illness requiring significant medical attention in the
past five years.
. "Normal" Group Description - The normal population totaled 34 subjects
of which 18 were males and 16 were females. None of the subjects were
hospitalized nor was there knowledge of their undergoing significant
medical attention at the time of sampling.
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o "Hospltal" Group Description - The hospital population totaled 59
subjects of which 50 were males and 9 were females. All were con-
fined on an In-patlent basis and were undergoing significant medical
attention at the time of sampling. A representative listing of the
diseased states is listed below:
o Rectal Tumor
o Senile Emphysema
o Hepatitis
o Trans Urethral Prostatectomy
o Fractured Pelvis
o Pneumonia
o Obstructive Jaundice
o Nephritis
o Cellulltis
o Appendectomy
AREA Ill - SAMPLINO EQUIPMENT
le Parotld - Our parotid fluid collector is a spring tension apparatus
that utilizes mechanical pressure rather than vacuum in order to keep
the cup securely in place over Stensen's duct. At the same time, the
pressure is not strong enough to restrict flow from the orifice.
Bilateral sampling is easily achieved with two of the devices. Both
the cup and cheek plate are machined from Delrin and the entire col-
lector can be autoclaved.
F-3
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!e Blood - The required blood samples were drawn using the Vacutainer
system. This allowed flexibility insofar as volume and choice of
anticoagulants (if needed) were concerned. All venipunctures were
performed by skilled medical technologists, thus affording a mini-
mum of discomfort to the subject. All tubes were promptly labeled
with subject's name and date immediately after phlebotomy.
24-hour urine specimens.
o Stimulant - The oral stimulant used to promote flow were sour crystal-
line pieces marketed under the tradename of "Regal Lemon Sours."
Stimulation was required in order to provide sufficient sample volume
for analysis of the required components and keep the sampling time to
approximately 15 minutes maximum.
AREA IV - SAMPLING PROCEDURE
Perhaps the most important part of the sampling protocol was that of placing
the subject at ease. This was accomplished by a brief explanation of equip-
ment, why we were conducting these tests (to find a better means of evalu-
ating an individual biochemically), and what the program hoped to accomp-
lish (to find correlations between parotid, blood, and urine). It was
noted that subjects prepared in this manner were much more relaxed and
willing to cooperate. Listed below are the stepwise procedures that were
followed in performing the body fluid collections on normal and hospitalized
populations.
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Io Parotld Collection
a. The subject was seated comfortably (if ambulatory) and rapport
was established as previously described.
b. Gathering of personal data on laboratory sheets.
c. The technician scrubbed his hands thoroughly.
d. Preliminary oral examination. This was necessary due to the
anatomical variation among people as to the size and location
of Stensen's duct. It was not a requirement for subjects to
remove dentures (if worn) in order to aff£x the parotid cups.
e. Insertion of collection cups.
f. Stimulation was initiated by placing a sour lemon drop on the
tongue. Parotid flow was followed by visual observation down
the collecting tube. When the first drop entered the pre-
weighed collection tube, a stopwatch was started. The first
minute of flow was considered a washing or flushing of the
gland and subsequently discarded. From one to four samples
were collected at known time increments and were labeled as
to subject name, date, and time increment immediately upon
completion. Later, the tubes containing the parotid fluid were
re-weighed, the tare subtracted and flow rates (as }{20) were
calculated on the basis of milliliters per minute.
g. A pulse rate was taken during the collection period.
h. Parotid collectors were removed and placed in a 70% alcohol
bath.
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Blood Collection
a. Upon completion of parotid fluid collection, the subject's arm
was prepared for venipuncture. A tourniquet was applied and
the anticubital area of the arm was thoroughly cleansed.
b. Venipuncture was performed and blood drawn into a predeter-
mined number and type of tube.
c. A bandage was applied to the site and a few minutes allowed for
subject recovery.
d. Blood tubes were promptly labeled with subject name and date.
. Urine Collection
a. Oral instructions were given at the same time the collection
bag was identified by subject name and date. This served to
reinforce the directions already on the bag as part of the label.
Subjects were asked to return bags to the central collection
area from where our technicians could transport them back to
the Fullerton laboratory facilities.
AREA V - CONTROL GROUP SAMPLING PROCEDURE
From each subject, a series of two urine, two blood, and five par.rid
samples were obtained. Sampllngwas undertaken approximately two hours
after eating. An initial urine, par.rid, and blood sample was taken.
The subject then commenced a body function routine which consisted of three
I0 minute exercise cycles with concomitant par.rid sampling. Following the
exercise, a final par.rid sample was collected during a 15 minute recovery
period. Subsequently the second blood and urine samples were taken.
F-6
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Appendix O
ANALYTICAL PROCEDURES
1.1
I. UREA NItrOGEN
REFERENCE
Chaney, A.L., and E.P. Narbach, Clln. Chem. 8, 131 (1962).
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1.2.2
1.2.3
1.2.4
1.3
1.3.1
REAGENTS
Buffered Urease Solution. 150 mg. urease (ca. 1000 U/g.) and
1.0 g. ethylene-diaminetetraacetic acid per 100 ml. aqueous
solution, adjusted to a pH of 6.5. The urease solution is
stable for i month in the refrigerator. Stability is much
greater in the frozen state.
Phenol Color Reagent. 50.0 g. phenol and 0.25 g. sodium
nitroprusslde per liter. Stable at least 2 months if kept
cool and in amber bottle protected from light.
Alkali-Hypochlorite Reagent. 25.0 g. NaOH and 40 ml. Clorox
per liter. Stable at least 2 months if kept cool and in amber
bottle protected from light.
Urea Standard. Place 0.2145 g. urea in a 1 1. volumetric
flask and make to volume with distilled water. Add a few
drops of chloroform as a preservative. Store in refrigerator.
1 ml. contains 0.1 mg. urea N.
PROCEDURE
Set up the following in test tubes:
Blank. 0.2 ml. buffered urease solution.
Standard. 0.2 ml. buffered urease molution and 20 ul. urea
s tandsrd.
Unknown, 0.2 ml. bqffered urease solution and 20 ul. serum
or parotid fluid.
C-I
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! 1.3.2
1.3.3
1.3.4
I 1.3.5
1.3.6
I
I 1.4
Incubate tubes in a water bath at 37°C. for 15 min. or at 25°C.
for 30 mtn. (these are minimum times).
Add 1.0 ml. phenol color reagent to each tube, mix, then add
1.0 ml. alkali-hypochlorite reagent and mix promptly again.
Incubate tubes at 37°C. for 20 min., or at 25°C. for 40 min.
Add 8 ml. water to each tube. Mix by inversion using clean
Saran Wrap or Parafilm '_l" over top of tube,
Read absorbances of blank (Ab), standard (As) , and unknown (Ax)
against water at 630 mu.
CALCULATION
I _ " A bmg. urea N/IO0 ml. = -- Ab
G-2
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2.1
2, CALCIUM, PAROTID FLUID AND SERUM
2.2
REFERENCE
Bachra, B. N,, Dauer, &., and A. E. Sobel, Clln. Chem.
_4, 107, (1958).
2,2,1
REAGENTS
2.2.2
KOHl I_25 N. Dismolve 70 g. KOH pellet in 500 ml. of water
and add water to I liter.
2.2.3
EDTA Solution. D188olv • 395 mK. dlsodlum ethylenedlamlne-
tetraacetate dtbydrate in 500 ml. water and add water to
I 2.2.4
I liter.
Cal-R_. d Indicator Solutlm1,. Grind 1.0 8. "Cal-Red Dilute" in
I0 ml. water. Not all the msterLml 8oe8 into solution. This
suspension is usually stable in the refrtserator for about
two weeks.
Capryltc Alcohol.
I 2.2.5 _al¢ium S_andard. Weigh out exactly 2SO mg. Iceland Spar and
transfer to a 1 liter volumetrlc flash. Add 7 ml. dilute HCl
I (I part cont. HCl + 9parts water), Let stand until solid is
dissolved, then add spproximstely 900 ml. water. Adjust pH toI
I
I
I
6.0 wlth 5070 ammonium acetate. Adjust volume to I liter with
water and mix. 1 ml = 100 ug Ca.
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2o3.1
_3_2
2.3.3
2.4
Add the following to clear, conlcal-tlpped 12 or 15 ml.
centrifuge tubes:
Standard. 0.50 ml. (50 us Ca).
Unknown. 0.50 ml. serum or parottd fluid and a very small
drop of caprylic alcohol.
Proceed with1 tube at a ttme (if samples remaln alkaline
for more than I0 mln., the end point is not sharp). Add
2.5 ml. 1.25 N KDH, mlx, and add 0.2 ml. indicator solutlon
(shake indicator solutlon well each time before pipettlng).
Immedlately tltrate with EDTA solution until color changes
from wlne-red to blue. Observe the color change by looking
throush the solution against an incandescent light.
CAlCInaTION
meq. Ca/1. = ml I unknown titration X $
ml. standard titration
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3.1
3.2
3.2.1
3.2.2
3.2.3
3.2.4
3.2.3
3.2.6
3.2.7
3.2.8
3,3
3.3.1
3. CALCIUM, URINE
REFERENCE
Bachra, B. N., Dauer, A., and A. E. Sobel, Clln. Chem. 4,
107, (1938).
ILlU_Glm'I"S
S3DH. I_25 N. See procedure 2.2.1.
EDTA Solution. See procedure 2.2.2.
Cal-Red Indiutor So_tCton. See procedure 2.2.3.
Sodium Citrate a 0t03 M. Dissolve 14.7 g- of the dthydrate
per liter water.
AmJmntum On late a 10_.
_BB. 27..
HC1. 1 N.
Calcium Standard. See procedure 2.2.4.
PitOCgmmE
If urine ts clear and no precipitate is seen cltn81ng to walls
of container, mix and remove approximately 10 ml. Acidify to
pH l with ceue. BCI. If precipitate is p_esent in origtnaI
urine, acidify the entire urine specimen to pH 1.
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3.3.2
3.3.3
3.3.5
3.3.6
3.3.7
3.3.8
3.4
Warm acidified speci_ to 60°C for st least 15 mln., mixing
occasionally.
Pipet 0.50 ml. urine from step 2 into a conical-tipped, 12 or
15 ml. centrifuse tube, add 0.I ml. 10% ammonium oxalate, and
mix. Add I drop of methyl red indicator and then 3_N_OH
dropwise to obtain orause color.
Plece in bo!|!n s water b_th for 20 man. Cool to room temper-
ature, centrifuge, decant supernatant fluid carefully, invert
and drain on absorbent paper.
Dissolve precipitate in 0.25 ml. I N HCf with warming and add
0.25 ml. 0.05 M sodium citrate.
To a clear, conical-tlpped centrifuge tube, pipet 0.5 ml. of
standard (50 ug Ca).
Proceed with 1 tube at a time (if samples remain alkaline
for more than 10 _tn., the end point is not sharp). Add
2.5 ml. 1.25 N KOH, mix, and add 0.20 ml. indicator solution
(shake indicator solution well each time before pipettinK).
Iumediately tttrate with EDTA solution until color changes
from wine-red to blue. Observe the color change by looking
throush the solution against an incandescent light.
CALCULATION
meq. Ca/1. urine = ml. unknawn titratioa X 5
ml. standard titratien
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4.1
4.2
4.2.1
4.2.2
4.3
4.3.1
4.3.2
4.3.3
4.3.4
4. TOTAL PROTEIN, SERUM (BIURET REACTION)
REFERENCE
Henry, R.J., Sobel, C., and S. Berkman, Anal. Chem. 29, 1491
(1957).
REACENTS
Biuret ReaKent. (a) Dissolve 17.3 g. CuSO 4 5H20 in about
!00 m!. hot water. (b) Dissolve !73,g. sodium citrate and
I00 g. anhydrous Na2CO 3 in about 800 ml. water by heating.
When cool, pour (a) into (b) while stirring and dilute to 1
I. at room temperature. Stable indefinitely at room temperature.
NaOH, 3%.
PROCEDURE
Set up in test tubes:
Reagent Blank. 5 ml. 3% NaOH.
Sample. Rinse 0.I ml. serum from a 0.i ml. TC pipet into
4.9 ml. of 3% NaOH.
Add I ml. bluret reagent to each tube and mix. This step should
follow step 1 without delay.
Wait at least 15 min., examine for Tyndall effect. If sample
is significantly turbld, add about 3 ml. of ether, shake
vlgorously for 30 sec., and centrifuge.
Read absorbance of sample against reagent blank at 545 mu.
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The All_cm, at 545 mu and 24°C. , reading against a reagent
blank, is 3.27.
g. protein/100 ml. - Ax x 18.35
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5.1
5.2
5.2.1
5.2.2
5.3
5.3.1
5.3.2
5.3.3
5.3.4
5.4
5. TOTAL PROTEIN, PAROTID FLUID (BIURET REACTION)
REFERENCE
Henry, R.J., Sobel, C., and S. Berkman, Anal. Chem. 29, 1491
(1957).
_A_S
Biuret Reagent. See procedure 4.2. I.
NaOH, 6l.
PROCE_JRE
Set up in test tubes:
Reagent Blank. 1.0 ml. water.
Sample. 0.5 ml. parotid fluid and 0.5 ml. water.
To each, add 1.0 ml. 6% NaOH and 0.4 ml. biuret reagent.
Wait at least 15 min., examine for Tyndall effect. If sample
is significantly turbid, add about 3 ml. of ether, shake
vigorously for 30 sec., and centrifuge.
Read absorbances of samples against reagent blank at 545 mu.
CALCIFuATION
mg. protein/100 ml. = 1468 A
G-9
i
I
i|
I
I
l
I
I
I
I
I
I
I
I
I
I
ii
6.1
6.2
6.2.1
6.2.2
6.2.3
6.2.4
6.2.5
6.2.6
6. GLUCOSE
2EI_ERINCE
Cawley, L.P., Spear, F.E., and R. Kendall, Am. J. Clln. Path. 32,
195 (1959).
Worthington Biochemlcal Corporation Instruction Manual.
RRA6ENTS
Zinc sulfate, 10_. 100 g. ZnSO 4 • 7H20/!iter.
NaOH, 0.SN. 20 g./liter.
Glucostat ReaKent (Northington Biochemical Corp., Freehold,
New Jersey). The reagents are supplied dry in a set of 2 vial.
Contents of the small vial (chromogen: 0-dianisidine) are
dissolved in 1 ml. of methyl alcohol and added to a 100 ml.
volumetric flask containing 50 ml. of distilled water. The
contents of the large vial (glucostat reagent: glucose oxfdase,
horseradish peroxidase, and phosphate buffer) are dissolved in
distilled water and added to the volumetric flask, which is
then diluted to volume. The reagent may be stored in a brown
bottle at -5°C. for several days without loss of activity.
HC1, 5N.
_tock Glucose Standard, 1Z. Use highest purity glucose.
with benzoic acid. Stable indefinitely in refrigerator.
contains 10 mg. glucose.
Saturate
1 ml.
Dilute Standard {i). Dilute I ml. of stock standard to 500 ml.
with water. I ml. contains 0.02 mg. glucose.
G-IO
I
l
I
I
I
I
I
I
I
l
i
6.2.7
6.3
6.3.1
6.3.2
6.3.3
6.4
6.4.1
Dilute Sta.ndard (b). Dilute 1 ml. of stock standard to 200 ml.
with water, i ml. contains 0.05 mg. glucose.
PREPARATION OF FILTRATES.
Plasma - Add 0.5 ml. plasma to 8.5 ml. H20 and mix. Add 0.5 ml.
zinc sulfate, mix, add 0.5 ml. 0.5N NaOH, and mix again.
Let stand 5 min. and filter.
Parotid _!uid - Add 0.5 ml. parotld fluid to 1.5 ml. H20 and
mix. Add 0.25 ml. zinc sulfate, mix, add 0.25
ml. 0.5 N NaOH, and mix again. Let stand 5 min.
and filter.
Urine - Neutralize the urine with the least amount of acid or
alkali. If appreciable amounts are required, the
dilution should be taken into account. It is convenient
to make a preliminary qualitative estimation with one
of the paper strip tests. Then dilute the urine to
contain from approximately 0.i to 0.3 mg. of glucose
per ml. to I0 ml. of urine, add ca. 0.5 g. of activated
charcoal. Stir and let stand 15 mln., then filter clear.
PROCEDURE
Set up in Test Tubes:
Reagent Blank.
Standard (1).
Standard (2).
Sample.
0.5 ml. H20.
0.5 ml. dilute standard (a).
0.5 ml. dilute standard (b).
0.5 ml. filtrate.
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At 15 second intervals, add 1.5 ml. of glucostat reagent to
each tube.
After exactly 30 min. for each tube, add 0.05 ml. 5N HCI and
mix.
Read absorbances of blank (Ab), standard (Asl or As2), and
sample (A x) against water at 410 mu.
CALCULATION
x
Plasma - _g. glucose/100 ml. " "
, _As 2 - A b
x 0.25 x I0__0 x 20
.5
Parotid Fluid - mg. glucose/100 ml. =
A x - Ab I00
x .01 x-- x 5
As I _ Ab .5
Uz£n____ee-mg. glucole/100 ml. =
Ax . Ab
Asl - Ab
x .01 x_. O. x dilution
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7. Ame0t8_ arJ:_. HLIXD o AND PAIOY_ FLUID
EF_
Sellgson, D., and E. Bit|hera, J.. Lab. C.!in. ,)fed. 49, 962
(1957).
knry, R.J., Clinical _qltrYt , _rtnciples and Techniques,
p. 327.
APPARATIU8
Diffusion bttles. Vaccine bottles, ca. 50-65 el. capacity,
dimensions ca. 2.5 x 1.5 in.
Rubber Stoppers. One set of solid stoppers to fit the above
bottles. A second set with one bole to fit the receiving rods.
bcelvlnR bds. 6 x 80 nm. glass rod vlth 0.5 in. of one end
grmmd so that when dipped in acid, it retains an acid film
over its surface. The rods are set in the one bole rubber
stopper so that when placed in the bottle the ground end of
the rod extends about half-way into the bottle.
Stainless 8_eel _ode. Approxtmtely 8 _. in diameter and 40
me. long. Three are required per bottle.
Rotator. A wheel, rotating about 50 r.p.m, with the axis
horisont81, to which spring clamps are attached to hold the
diffusion bottle about 8 cm. from the axis and with the flat
botto_ of the bottle against the wheel.
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Alkalin e K_.ture. 2 parts o£ IC2C03 , l_ H20 plus I part
J3_O 3. Mix thoroughly but do not powder. Dry or partially
dry r_co 3 will cause the blood to clump and become warm.
To keep salts moist, store in a closed container over saturated
r m3.
II _4" I part cone. U2W4 in 3s parts of water.
_henol _o_or leaxent. See Urea procedure 1.2.2.
_kali-Hynochlorite Realent. See Urea procedure 1.2.3.
_ockAmo. nia Standard, 0.1 mg. N/ml. Dissolve 0.472 8.
(_)2804, A.I. 8fade, in distilled water in a 1 liter
vol_etric flash. Add a few drops of cont. H2SO4, then dilute
to 1 liter with water. Stable indefinitely.
MorkinaA_ouia |tender4, 2 jpS. i/ml. Dilute 2.0 ml. stock
a_onia standard to 100 ml.
lqmClmgU
7.4.2
kt up a series of diffusion bottles (2 blanks, 2 standards
and 2 for each unknmm) containing 3.0 S. alkaline buffer
mixture and 3 dry stainless steel rods. To each add 1.0 ml.
a20.
bt up bottles in follmeinK order:
Add 1.0nl. distilled water to bottle and
l_aJdiatel_ ,topper.
7.4.3
7.4.4
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7.4.8
Standard.
_nknown.
Add 1.0 ml. working standard (2pg NH3N )
to bottle and immediately stopper.
Add 1.0 ml. sample to bottle.
Mix on rotator for 1 min. Working with one bottle at a time,
vet the ground portion of s receiving rod in IN H2S04, remove
the rubtmr stopper from the bottle while it is lying on its
side, and qulckly insert the receiving rod with stopper,
taking care not to touch the neck of the bottle as the rod
is inserted.
btate at 50 r.p.m, for 40 _tn.
Remove bottles from rotator and lay them down gently on
their sides. Remove receiving rods one at a time carefully
from the bottles, taking great care that the rod does not
touch the neck of the bottle. Wash the acid off the receiving
rod into a test tube with 1.0 ml. Phenol Color Reagent. Next,
wash off the rod successively with 1.0 ml. alkali-hypochlorite
reagent and 1.0 ml. H20.
Incubate in a water bath at 37°C for 20 min., or at 25°C for
40 min.
Add 5 ml. H20 to all tubes mix.
Read Absorbance of blank (Ab) , standard (as) , and unknown (Ax)
against water at 630 mu. If Ax is greater than 0.8, dilute
the blank and unknown wLth water equally, read absorbance
again, and make proper 6orrections in calculation.
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_g ammonia = I/I00 ml. - As . Ab
x 2 x I00
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8. ON-SI_ ANALYSIS OF pH, pCO2, PO2, AND HCO3 IN BLOOD
AND PAROTID FLUID
gEFE_NCE
Henry, R.J., Clinical Chemistry: Principles and Techniques,
pp. 435 - 467, 1954.
Model 160 Fhysiologlcal Gas Analyzer Instruction Manual,
Published by Splnco Division, Beckman !nstrvLments, Inc., 1962.
APPARATUS
The Beckman Modular Cuvette.
Beckman Oxygen Macro Electrode.
Severinghaus - type pCO2 Electrode.
Beckman Micro Blood pH Electrode.
The Model 160 Physiological Gas Analyzer.
Electrode Charging Material.
A 0-I00 my. range potentiometric strip chart recorder.
Oiled heparinized glass syringes for blood drawing.
Fre-weighed test tubes containing 0.5 ml. of mineral oil for
anaerobic parotid fluid collection.
Compressed gases: 2_ CO 2 in nitrogen and 5Z CO 2 in nitrogen
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I 8.3.1 Calibration of Electrodes Proper settings in mm. Hg for the
pCO 2 content of the calibrating gases were made in accordance
i with the followi formula:
| barometric _ partial pressure_
Setting in -_.Hg % of calibration CO2 x ( pressure of H?0 vapor "
I00
I Partial pressure of water vapor @ 37°C is 47 mm. Hg. Both pCO 2
I
I
I
I
I
+ pO 2 electrodes were operated in a saturated water vapor
environment at 37°C.
Zero pO 2 was set against either one of the pCO 2 calibration gases.
High pO 2 setting was made using room air (21% 02 content) and
substituting in the above equation.
Standard pH buffers corrected to 37°C were used to calibrate the
pH electrode and to test span.
8.3.2 Bloo____d.- Blood was drawn anaerobically from the antlcubital vein into
heparlniaedp oiled syringes. No tourniquet was used. After
the proper amount of blood had been withdrawn, a few drops of
mercury were drawn up into the syringe in order to effectively
mix the sample. Immediately after mixing, the blood was charged
into the cuvettes and values read out on the Gas Analyzer after
an appropriate time lapse. Electrode drift was followed on the
strip chart recorder and readings were taken until equilibrium
had been reached. At loast two repetitions of each function
were made.
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_a. rotid. - The proper volume of parotld fluid was collected
anaerobically (under a layer of mineral oil) and aspirated into
the cuvettes. Neaeurement procedure was identical to that of
whole blood.
Followins each series of maourements, the euvette sample lines
were flushed with distilled H20 followed by isotonic saline
prior to tho introduction of a new specimen.
Calculation of !_03" based on the determination of pH and pCO2 .
The value of _"0 3 concentration was calculated from the well-
known Handerson-HssJelbalch equation by proper substitution:
o co:')
pli- 6.10 + log 0.0314 pCO2
C-19
9.1
9.2
9.2.1
9.2.2
9.2.3
9.3
9.3.1
9. CHOLINESTERASE
REFERENCE
Michel, H.O., J. Lab. Clln. Med., 34, 1564 (1949).
Michel, H.O., Standard _thods of Clinical Chemistry, Vol. 3,
ed. D. Sellgson, Academic I_ess, N.Y., p. 93, 1961.
REAGENTS
Stock Buffer. - Place 44.73 g. KC1 in a 250 m!. graduated beaker.
Add hot distilled water to ca. 175 ml. and dissolve the salt.
Wash 4.124 g. sodium barbital into a 200 ml. volumetric flask
with about 100 ml. of the KC1 solution and the sodium barbital
dissolved by shaking. Dissolve 0.545 g. KH2PO 4 in about 50 ml.
of the KC1 solution in a beaker. This solution and remaining
KC1 solution are transferred to the volumetric flask. Rinse
beakers and add rinse to volumetric flask. Dilute to 200 ml.
Store at room temperature in a polyethylene bottle.
Workin_ Buffer Solution. - To 6.4 ml. stock buffer, add about
80 ml. H20 and 8 ml. 0.01N HCl. Adjust pH to 8.00. Dilute to
100 ml. with water. When pH has dropped .05 pH unit, fresh
buffer should be prepared.
Substrate. - To I00 mg. of acetylchollne chlorlde in a 15 ml.
graduated tube, add water to 3.3 ml.
PROCEDURE
Standardize the pH mater with phospate buffer of about pH 7 and
check operation with re_erence standards of lower pH. If electrodes
have been used previously for alkaline solutions, soak in 0.1N
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HC1 for i0 mln. prior to use.
Serum. - To 5 ml. dfstilled water in a 50 ml. beaker, add 0.10
ml. serum from a T.C. pipet, followed by 5 ml. working buffer
solution. Bwirl to mix and let stand at 25°C for about 10 mln.
Parotld Fluid. - To 1.0 ml. parotld fluid in a 5 ml. beaker, add
1.0 ml. working buffer solution. Mix and let stand 10 mln. at
25°C.
Take the pH of sample, rinsing the electrodes with distilled
water and wiping dry wlth tissue prior to each measurement. This
is pH I. Add I ml. substrata to serum sample or 0.2 ml. substrate
to parotld fluid sample. Hix and note time. Times of addition of
substrate to a series of samples should be staggered, e.g., at
I or 2 sln. intervals.
After 55 mln., restandardlze pH meter. Take pH's of samples
exactly 1 hour after addition of substrate. This is pH 2.
CALCULATION
SERUH chollnesterase units _ApH/hr.
ffi pH 1 - pH 2 - b
pH/hr.
PAROTID FLUZD choltnesterase units - 50
The value for b is obtained from the following table: (correction
for the drop in pH resulting from non-ensy_tic hydrolysis during
the period of incubation)
pH Z b pH 2 b pH 2 b
7.9 0.09 7.5 0.04 7.1 0.02
7.8 0.07 7.4 0.03 7.0 0.01
_.7 _.06 7.3 0.02 6.8 0.01
7.6 0.05 7.2 0.02 6.6 0.01
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MA_RIAL Se_itivity* Recovery** Frec is ion***
Ammonla-N 10=2 ppm IOOZ _+ 8Z
Calcium 8 x 10-2 ppm 95Z _+ 3Z
Protein 10 ppm _+ 3Z
Urea-N 1 ppm 95Z _ 10Z
Glucose 1 ppm 92% _+ 27,
BicaEoonnte + 2Z
po 2 1 mm of _8 lOOZ + 27,
pCO 2 1 mm of Hg 106% _+ IZ
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I
* The tallest amount of material which will produce a change in the
reading.
** The percent of material recovered when added tO parotid £1uid
*** The random error s the variation of results obtained by a method
when the same sample is run Espeatedly
G-22
